PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCitius Pharmaceuticals
Citius Pharmaceuticals(CTXR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SuprenzaPhentermine2011-06-132028-2029
Obesity
,
Pain
,
Epilepsy
,
Lennox gastaut syndrome
,
Infantile spasms
,
Partial epilepsies
,
Tonic-clonic epilepsy
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bos taurus adrenal cortex corticosteroids
hematologic neoplasms
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloproliferative disorders
,
primary myelofibrosis
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myelomonocytic leukemia chronic
,
prolymphocytic leukemia
,
refractory anemia with excess of blasts
,
b-cell leukemia
,
drug-related side effects and adverse reactions
,
hematopoietic stem cell transplantation
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
atopic dermatitis
,
eczema
,
pruritus
,
pregnancy rate
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use